GENESISBiotechnology
Genesis IBRC India Ltd — Quarterly Results & Earnings
₹98.98
+0.00%
Profit Growth YoY-101.64%Latest quarter
Sales Growth YoY-100.00%Latest quarter
Sales CAGR 5YN/A5 year compound
Profit CAGR 5Y105.89%5 year compound
📋
Quarterly Performance
YoY Profit Growth-101.64%
🔴 Significant decline
YoY Sales Growth-100.00%
🔴 Significant decline
OPM 5Y Average
N/AOperating profit margin
EPS Growth 5Y
105.89%Interest Coverage
N/AHigher = safer debt servicing
ROE
51.62%ROCE
51.62%💡
Growth Analysis
Genesis IBRC India Ltd reported YoY profit growth of -101.64% and revenue growth of -100.00% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at N/A and profits at 105.89% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Genesis IBRC India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.